Bicyclic pyrazolone cytokine inhibitors

Details for Australian Patent Application No. 2004289691 (hide)

Owner The Procter & Gamble Company

Inventors Clark, Michael Philip; Golebiowski, Adam; Brugel, Todd Andrew; Laughlin, Steven Karl; Sabat, Mark

Agent Pizzeys

Pub. Number AU-B-2004289691

PCT Pub. Number WO2005/047287

Priority 60/518,886 10.11.03 US

Filing date 9 November 2004

Wipo publication date 26 May 2005

Acceptance publication date 23 April 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/047287 Priority application(s): WO2005/047287

23 April 2009 Application Accepted

  Published as AU-B-2004289691

20 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289693-Oxidation process and catalyst

2004289690-Benzylether amine compounds useful as CCR-5 antagonists